½ÃÀ庸°í¼­
»óǰÄÚµå
1620471

¼¼°èÀÇ ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü ±â±â ½ÃÀå : ¼ºÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)

Medical Cold Chain Storage Equipment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÀÇ·á¿ë ÄݵåüÀÎ º¸°ü ±â±â ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 29¾ï ´Þ·¯·Î, 2024-2032³âÀÇ CAGRÀº 5.3%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÄݵåüÀÎ º¸°ü ±â±â´Â ¹é½ÅÀ̳ª »ý¹° Á¦Á¦ µî ¿Âµµ¿¡ ¹Î°¨ÇÑ ÀÇ·á Á¦Ç°ÀÇ ¾ÈÀüÇÑ ¿î¼Û°ú º¸°üÀ» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿Âµµ³ª ½Àµµ ·¹º§À» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ¾î °ø±Þ¸Á Àü¹Ý¿¡ °ÉÃÄ Á¦Ç°À» ÃÖÀûÀÇ »óÅ·ΠÀ¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.

°Ô´Ù°¡ ÃßÀû¼º°ú Åõ¸í¼ºÀ» ³ôÀ̰í À§Á¶Ç°ÀÇ ¹æÁö³ª ÀǾàǰÀÇ ÁøÁ¤¼º È®º¸¿¡ µµ¿òÀÌ µÇ´Â ºí·ÏüÀÎ ±â¼úµµ °ËÅäµÇ°í ÀÖ½À´Ï´Ù. Áß¼Ò±â¾÷À̳ª ½ÅÈï±¹ ½ÃÀå¿¡ À־ °úÁ¦°¡ µË´Ï´Ù. ±ÔÁ¦ Áؼö¿Í °ü·ÃµÈ º¹ÀâÇÑ ¹°·ù´Â Á¦´ë·Î °ü¸®ÇÏÁö ¾ÊÀ¸¸é ºñÈ¿À²ÀûÀÏ ¼ö ÀÖ½À´Ï´Ù. È¥¶õÀÇ ¿µÇâÀ» ¹Þ±â ½±°í Á¦Ç°ÀÇ ¹«°á¼ºÀÌ ¼Õ»óµÉ ¼ö ÀÖ½À´Ï´Ù.

ÀåºñÀÇ °æ¿ì ³Ãµ¿°í ºÎ¹®Àº 2023³â¿¡ ¾à 11¾ï ´Þ·¯¸¦ âÃâÇϰí 2024-2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 5.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÊÀú¿Â ³Ãµ¿°í ¼ö¿ä´Â ƯÈ÷ ¹é½Å º¸°ü¿ëÀ¸·Î ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¿¡³ÊÁö È¿À²ÀÌ ³ôÀº ±â¼ú°ú ģȯ°æ ³Ã¸ÅÀÇ ±â¼ú Çõ½ÅÀ» ÃßÁøÇÏ°í ¿î¿µ ºñ¿ë°ú ȯ°æ ºÎÇÏ ¸ðµÎ °¨¼Ò ÀǾàǰ ºÎ¹®Àº 2023³â ½ÃÀå Á¡À¯À²ÀÇ ¾à 33%¸¦ Â÷ÁöÇßÀ¸¸ç 2032³â CAGRÀº 5.6%·Î ¿¹»óµË´Ï´Ù. »ý¹° Á¦Á¦ ¹× ¹é½ÅÀÇ º¸°ü ¹× ¿î¼Û¿¡ °üÇÑ ±ÔÁ¦ ¿ä°ÇÀ¸·Î Á¦¾à ȸ»ç´Â ºÎÆÐ À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇÑ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â IoT ´ëÀÀ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ µî ÃÖ÷´Ü ÀåºñÀÇ µµÀÔÀ» ÁøÇàÇϰí ÀÖ½À´Ï´Ù. 2023³âÀÇ Á¡À¯À²Àº ºÏ¹Ì°¡ 32%·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç, 2032³âÀÇ CAGRÀº 5.4%·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. °³¹ß, ¿¬±¸ °³¹ßÀÇ Áö¼ÓÀûÀÎ ³ë·ÂÀÔ´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ³â 2023³â
¿¹Ãø³â 2024-2032³â
½ÃÀÛ±Ý¾× 29¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 46¾ï ´Þ·¯
CAGR 5.3%

FDA ¹× CDC¿Í °°Àº ´ç±¹ÀÇ ¾ö°ÝÇÑ ±ÔÁ¦´Â ÀǾàǰÀÇ Á¤È®ÇÑ º¸°ü Á¶°ÇÀ» ¿ä±¸Çϰí ÀÖÀ¸¸ç, º´¿ø°ú Á¦Á¶¾÷ü´Â Áؼö Àåºñ¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ÃßÀû ¹× ¿Âµµ ÆíÂ÷ ÀÚµ¿ °æº¸´Â ÄݵåüÀÎ º¸°üÀÇ ½Å·Ú¼º°ú È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀο¡ ¿µÇâÀ» ÁÖ´Â ¿äÀÎ.
    • ÀÌÀÍ·ü ºÐ¼®
    • º¯Çõ
    • Àå·¡ÀÇ Àü¸Á
    • Á¦Á¶¾÷ü
    • À¯Åë¾÷ü
  • »ê¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¹é½Å°ú »ý¹°Á¦Á¦ ¼ö¿ä Áõ°¡
      • ¹ÙÀÌ¿ÀÀǾàǰ»ê¾÷ÀÇ ¼ºÀå
    • »ê¾÷ÀÇ ÀáÀçÀû ¸®½ºÅ© ¹× °úÁ¦
      • ³ôÀº Ãʱâ ÅõÀÚ
      • °ø±Þ¸ÁÀÇ È¥¶õ
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ¹Ì·¡ µ¿Ç⠺м®
  • °¡°Ý ºÐ¼®
  • ±â¼úÀû Àü¸Á
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ±â±â À¯Çüº°

  • ÁÖ¿ä µ¿Çâ
  • ³ÃÀå°í
    • ½ÇÇè½Ç¿ë ³ÃÀå°í
    • Ç÷¾×ÀºÇà¿ë ³ÃÀå°í
    • ¾à±¹¿ë ³ÃÀå°í
    • Å©·Î¸¶Åä±×·¡ÇÇ¿ë ³ÃÀå°í
  • ³Ãµ¿°í
    • ÃÊÀú¿Â ³Ãµ¿°í
    • ÇöóÁ ³Ãµ¿°í
    • ¼îÅ© ÇÁ¸®Àú
  • ±ØÀú¿Â ÀúÀå ½Ã½ºÅÛ
    • ¾×ü Áú¼Ò ÀúÀå ½Ã½ºÅÛ
    • ±â»ó º¸Á¸ ½Ã½ºÅÛ
  • ³ÃÀå½Ç
  • ±âŸ(¾ÆÀ̽º ¶óÀÎµå ³ÃÀå°í, ¼Ö¶ó Á÷Á¢ µå¶óÀÌºê ³ÃÀå°í µî)

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¿Âµµ´ëº°

  • ÁÖ¿ä µ¿Çâ
  • 2-8¡É
  • -20 - -40¡É
  • -40 - -80¡É
  • 80¡É ÀÌÇÏ

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¿ë·®º°

  • ÁÖ¿ä µ¿Çâ
  • ¼ÒÇü(300¸®ÅÍ ÀÌÇÏ)
  • ÁßÇü(300-700¸®ÅÍ)
  • ´ëÇü(700¸®ÅÍ ÀÌ»ó)

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ±â¼úº°

  • ÁÖ¿ä µ¿Çâ
  • ÄÄÇÁ·¹¼­ ¹æ½Ä
  • Èí¼ö½Ä ½Ã½ºÅÛ
  • ¿­Àü½Ä

Á¦9Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¿ëµµº°

  • ÁÖ¿ä µ¿Çâ
  • ¹é½Å º¸°ü
  • Ç÷¾×¡¤Ç÷¾× Á¦Á¦ º¸°ü
  • »ý¹° »ùÇà º¸°ü
  • ÀǾàǰ º¸°ü
  • ±âŸ(Àå±â º¸Á¸, ¼¼Æ÷ ¹è¾ç¾× µî)

Á¦10Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø ¹× Ŭ¸®´Ð
  • Á¦¾àȸ»ç
  • Á¶»ç ½ÇÇè½Ç
  • Ç÷¾×ÀºÇà
  • ¾à±¹
  • ±âŸ(Çмú±â°ü, Áø´Ü¼¾ÅÍ µî)

Á¦11Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä µ¿Çâ :Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ³²¾ÆÇÁ¸®Ä«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Azenta
  • Binder
  • Cardinal Health
  • Carebios Biological Technology
  • Darwin Chambers
  • Elanpro
  • Farrar
  • Haier Biomedical
  • Hoshizaki America
  • Kendall Cold Chain System
  • Memmert
  • Philipp Kirsch
  • Roemer Industries
  • Summit Appliance
  • Thalheimer Kuhlung
JHS 25.01.09

The Global Medical Cold Chain Storage Equipment Market was valued at USD 2.9 billion in 2023 and is projected to grow at 5.3% CAGR from 2024 to 2032. The rising demand for pharmaceuticals, fueled by medical advancements and an aging population, drives the market growth. Cold chain storage plays a critical role in ensuring the safe transport and storage of temperature-sensitive medical products, such as vaccines and biologics. Technological advancements are reshaping the cold chain storage industry. The integration of Internet of Things (IoT) technology allows for real-time monitoring of temperature and humidity levels, ensuring that products remain within optimal conditions throughout the supply chain.

Additionally, blockchain technology is being explored to enhance traceability and transparency, helping to prevent counterfeit products and ensuring the authenticity of pharmaceuticals. However, high initial costs for advanced technology and infrastructure pose challenges, particularly for smaller companies and developing markets. Complex logistics related to temperature control, transportation, and regulatory compliance can lead to inefficiencies if not properly managed. Moreover, cold storage's reliance on consistent power supplies makes it susceptible to disruptions from grid failures or natural disasters, which can compromise product integrity.

In terms of equipment, the freezer segment generated around USD 1.1 billion in 2023 and is expected to grow at a CAGR of 5.9% from 2024 to 2032. Demand for ultra-low temperature freezers has surged, particularly for vaccine storage, driving innovation in energy-efficient technologies and environmentally friendly refrigerants, reducing both operational costs and environmental impact. The pharmaceutical sector accounted for roughly 33% of the market share in 2023 and is anticipated to grow at a CAGR of 5.6% through 2032. With a growing number of temperature-sensitive drugs, manufacturers are increasingly investing in advanced cold chain solutions. Regulatory requirements for the storage and transport of biologics and vaccines have prompted pharmaceutical companies to adopt cutting-edge equipment, including IoT-enabled monitoring systems that provide real-time data to minimize spoilage risks. North America led the market with a 32% share in 2023 and is expected to grow at a CAGR of 5.4% through 2032. The regional growth is driven by increasing demand for injections and biologics, healthcare infrastructure development, and ongoing R&D efforts.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$2.9 Billion
Forecast Value$4.6 Billion
CAGR5.3%

Strict regulations from authorities like the FDA and CDC require precise storage conditions for pharmaceuticals, pushing hospitals and manufacturers to invest in compliant equipment. Additionally, advancements in IoT and smart monitoring systems are enhancing the reliability and efficiency of cold chain storage through real-time tracking and automated alerts for temperature deviations

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model.
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain.
    • 3.1.2 Profit margin analysis.
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for vaccines and biologics
      • 3.2.1.2 Growth in biopharmaceutical industry
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High initial investment
      • 3.2.2.2 Supply chain Disruptions
  • 3.3 Growth potential analysis
  • 3.4 Future trend analysis
  • 3.5 Price analysis
  • 3.6 Technological landscape
  • 3.7 Regulatory framework
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Equipment Type (USD Billion) (Thousand Units)

  • 5.1 Key trends
  • 5.2 Refrigerators
    • 5.2.1 Laboratory refrigerators
    • 5.2.2 Blood bank refrigerators
    • 5.2.3 Pharmacy refrigerators
    • 5.2.4 Chromatography refrigerators
  • 5.3 Freezers
    • 5.3.1 Ultra-low temperature freezers
    • 5.3.2 Plasma freezers
    • 5.3.3 Shock freezers
  • 5.4 Cryogenic storage systems
    • 5.4.1 Liquid nitrogen storage systems
    • 5.4.2 Vapor phase storage systems
  • 5.5 Cold rooms
  • 5.6 Others (ice lined refrigerators, solar direct drive refrigerators etc.)

Chapter 6 Market Estimates & Forecast, By Temperature Range (USD Billion) (Thousand Units)

  • 6.1 Key trends
  • 6.2 2°C to 8°C
  • 6.3 -20°C to -40°C
  • 6.4 -40°C to -80°C
  • 6.5 Below -80°C

Chapter 7 Market Estimates & Forecast, By Capacity (USD Billion) (Thousand Units)

  • 7.1 Key trends
  • 7.2 Small (up to 300 liters)
  • 7.3 Medium (300-700 liters)
  • 7.4 Large (above 700 liters)

Chapter 8 Market Estimates & Forecast, By Technology (USD Billion) (Thousand Units)

  • 8.1 Key trends
  • 8.2 Compressor-based systems
  • 8.3 Absorption-based systems
  • 8.4 Thermoelectric-based systems

Chapter 9 Market Estimates & Forecast, By Application (USD Billion) (Thousand Units)

  • 9.1 Key trends
  • 9.2 Vaccine storage
  • 9.3 Blood & blood products storage
  • 9.4 Biological sample storage
  • 9.5 Drug & pharmaceutical storage
  • 9.6 Others (organ storage, cell culture media etc.)

Chapter 10 Market Estimates & Forecast, By End Use (USD Billion) (Thousand Units)

  • 10.1 Key trends
  • 10.2 Hospitals & clinics
  • 10.3 Pharmaceutical companies
  • 10.4 Research laboratories
  • 10.5 Blood banks
  • 10.6 Pharmacies
  • 10.7 Others (academic institutions, diagnostic centers etc.)

Chapter 11 Market Estimates & Forecast, By Region (USD Billion) (Thousand Units)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 India
    • 11.4.3 Japan
    • 11.4.4 Australia
    • 11.4.5 South Korea
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
  • 11.6 MEA
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 South Africa

Chapter 12 Company Profiles

  • 12.1 Azenta
  • 12.2 Binder
  • 12.3 Cardinal Health
  • 12.4 Carebios Biological Technology
  • 12.5 Darwin Chambers
  • 12.6 Elanpro
  • 12.7 Farrar
  • 12.8 Haier Biomedical
  • 12.9 Hoshizaki America
  • 12.10 Kendall Cold Chain System
  • 12.11 Memmert
  • 12.12 Philipp Kirsch
  • 12.13 Roemer Industries
  • 12.14 Summit Appliance
  • 12.15 Thalheimer Kuhlung
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦